Euclidean Capital LLC
Source: SEC Form 13F · as of Mar 2026Euclidean Capital LLC holds 6 biotech & pharma companies tracked by BioSniper, totaling $29.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
6
Total value held
$29.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Oric Pharmaceuticals, Inc. (ORIC)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ORICOric Pharmaceuticals, Inc. | 989,410 | $12.5M |
| FHTXFoghorn Therapeutics Inc. | 1,573,761 | $7.5M |
| PMVPPMV Pharmaceuticals, Inc. | 2,627,643 | $3.3M |
| ALECAlector, Inc. | 1,307,858 | $2.8M |
| SRZNSurrozen Inc. | 87,696 | $2.6M |
| TNYATenaya Therapeutics, Inc. | 1,015,705 | $703K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.